[Federal Register Volume 64, Number 123 (Monday, June 28, 1999)]
[Notices]
[Pages 34658-34659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-16298]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention, Food and Drug
Administration, and National Institutes of Health
Development of a Public Health Action Plan to Combat
Antimicrobial Resistance
The Centers for Disease Control and Prevention (CDC), Food and Drug
Administration (FDA), and National Institutes of Health (NIH) announce
an open meeting concerning antimicrobial resistance.
Name: Development of a Public Health Action Plan to Combat
Antimicrobial Resistance.
Times and Dates: 10:30 a.m.-6 p.m., July 19, 1999. 8a.m.-6 p.m.,
July 20, 1999. 8a.m.-3:30 p.m., July 21, 1999.
Place: Sheraton Atlanta Hotel, 165 Courtland at International
Boulevard, Atlanta, Georgia 30303.
Status: Open to the public, limited only by the space available.
Purpose: To solicit input from invited consultants regarding
items to be included in a Public Health Action Plan that, when
published, will serve as a blueprint for activities of Federal
agencies to combat antimicrobial resistance. The Plan is being
developed by a Task Force composed of Federal personnel from several
Federal agencies and departments, co-chaired by CDC, FDA, and NIH.
The focus of the Plan will be on domestic activities.
Matters To Be Discussed: The agenda will focus on the following
topics related to antimicrobial resistance:
1. Surveillance
2. Prevention and control
3. Research
4. Product development
Comments and suggestions from the consultants for specific
action items for Federal agencies related to each of these topics
will be taken under advisement by the task force. The Task Force may
also utilize other sources of information in developing the Action
Plan. The agenda does not include development of consensus
positions, guidelines, or discussions or endorsements of specific
commercial products.
Agenda items are subject to change as priorities dictate.
Limited time will be available for oral comments and suggestions
from the public. Written comments and suggestions from the public
are encouraged and should be received by the contact person listed
below by August 22, 1999.
Persons anticipating attending the meeting are requested to send
written notification by July 12, 1999, including name, organization
(if applicable), address, phone, fax, and email addresses to the
contact below.
[[Page 34659]]
FOR FURTHER INFORMATION CONTACT: Minnie Johnson, Antibiotic
Resistance, NCID, CDC, M/S C-20, 1600 Clifton Road, NE, Atlanta,
Georgia 30333, telephone 404/639-2603, fax 404/639-4139, E-mail:
mlj2@cdc.gov.
The Director, Management Analysis and Services office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: June 21, 1999.
Carolyn J. Russell,
Management Analysis and Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 99-16298 Filed 6-25-99; 8:45 am]
BILLING CODE 4163-18-P
